Lv5
1230 积分 2021-08-18 加入
311eP Exploration of the mechanism of anlotinib in reversing PD-1 immunotherapy resistance: Insights from single-cell sequencing
15小时前
已完结
Successful treatment of severe lung cancer caused by third-generation EGFR-TKI resistance due to EGFR genotype conversion with afatinib plus anlotinib
16天前
已完结
Multiomics Prediction of Response Rates to Therapies to Inhibit Programmed Cell Death 1 and Programmed Cell Death 1 Ligand 1
2个月前
已完结
Dealing with KRAS G12C inhibition in non-small cell lung cancer (NSCLC) – biology, clinical results and future directions
2个月前
已完结
Bleeding with vascular endothelial growth factor tyrosine kinase inhibitor: A network meta-analysis
3个月前
已完结
HER2 testing: evolution and update for a companion diagnostic assay
3个月前
已完结
Zongertinib in Previously Treated HER2-Mutant Non–Small-Cell Lung Cancer
3个月前
已关闭
Small cell lung cancer
4个月前
已完结
Late-line options for patients with metastatic colorectal cancer: a review and evidence-based algorithm
4个月前
已完结
Integrative spatial analysis reveals tumor heterogeneity and immune colony niche related to clinical outcomes in small cell lung cancer
4个月前
已完结
皖公网安备34019202002308
